Merck & Co., Inc. $MRK Stake Trimmed by CX Institutional
Merck & Co., Inc. $MRK Stake Trimmed by CX Institutional MarketBeat
Covered in this story
What has happened since
- Merck & Co. is down 3.3% since this was published, 2 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Merck & Co.
- Scotiabank: $149 → $180 by Sep 2027 · sector outperform via marketbeat.com
- Argus Research: $130 → $145 by Aug 2027 · Buy via GuruFocus
- Guggenheim: $128 → $146 by Aug 2027 · buy via GuruFocus
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $MRK yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Merck & Co. →Dalsna Finance is currently tracking 32 stories mentioning Merck & Co., the earliest published 26 Jun 2026.
Summary aggregated from MarketBeat's public RSS feed. The full reporting belongs to MarketBeat — please read it on their site.